We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Science 37 Holdings Inc (SNCE) USD0.0001

Sell:$7.70 Buy:$9.36 Change: $0.07 (0.80%)
Market closed |  Prices as at close on 27 January 2022 | Switch to live prices |
Change: $0.07 (0.80%)
Market closed |  Prices as at close on 27 January 2022 | Switch to live prices |
Change: $0.07 (0.80%)
Market closed |  Prices as at close on 27 January 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Science 37 Holdings Inc., formerly LifeSci Acquisition II Corp., is a provider of technology-based solutions that enable decentralized clinical trials. The Company develops Decentralized Clinical Trial Operating System (DCT OS), which enable workflow orchestration, evidence generation and data harmonization on a platform. Its platform configures studies and fused with its networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices. Its offerings include Fully DTC, Metasite, Technology+, Study Configuration and Diversity & Inclusion. Its technology and virtual capabilities ranging from executing a virtual clinical trial, to supplementing a trial as a virtual site, to enabling clinical trials through technology. The company’s customer base consists of pharmaceutical corporations, biotech companies, and academic and governmental institutions.

Contact details

600 Corporate Pointe, Suite 320
United States
+ ()

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$936.01 million
Shares in issue:
114.71 million
Life Sciences Tools & Services
United States
US dollar

Key personnel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.